Sort
261,768 grants matching “gene therapy”
Transplant Tolerance in Non-Human Primates
$3,480,972Christian P Larsen · Emory University · U19 · FY2014 · AI
Transplant Tolerance in Non-Human Primates
$3,480,971Christian P Larsen · Emory University · U19 · FY2016 · AI
Identifying Relapse Predictors and Therapeutic Vulnerabilities in Ph+ and Ph-like Acute Lymphoblastic Leukemia
$3,480,276Mignon Lee-Cheun Loh · Seattle Children'S Hospital · R01 · FY2025 · CA
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
$3,478,888Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah · U01 · FY2025 · NS
Human Biochemical Genetics
$3,478,846William Gahl · National Human Genome Research Institute · ZIA · FY2023 · HG
The Therapy of CML
$3,477,908Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
Children's Oncology Group Chair's Grant
$3,476,591National Childhood Cancer Foundation · U10 · FY2005 · CA
Sirtuins and nuclear receptors in aging and age-associated diseases
$3,474,264Xiaoling Li · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells
$3,473,893Trevor K Archer · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
DCTD Functional Genomics
$3,472,000Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA
BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study
$3,470,697E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2020 · AG
A Safety and Efficacy Study of AAV2-hAADC for AADC Deficiency
$3,470,061Krystof S Bankiewicz · Ohio State University · R01 · FY2022 · NS
Vaccines for fentanyl and its derivatives: A strategy to reduce illicit use and overdose
$3,466,385Marco Pravetoni · University Of Washington · UH3 · FY2024 · DA
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,465,506Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,464,609Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Discovery and validation of a new long noncoding RNA as a novel target for neuropathic pain
$3,464,207Yuan-Xiang Tao · Rbhs-New Jersey Medical School · RF1 · FY2019 · NS
Early Biomarkers of Autism Spectrum Disorders in infants with Tuberous Sclerosis
$3,463,622Mustafa None Sahin · Boston Children'S Hospital · U01 · FY2014 · NS
Ethnic/Racial Variation in Intracerebral Hemorrhage (ERICH)
$3,462,738Daniel Woo · University Of Cincinnati · U01 · FY2012 · NS
Prostate Cancer Imaging
$3,460,723Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Hair Cell Development in the Mammalian Cochlea
$3,460,046Matthew Kelley · National Institute On Deafness And Other Communication Disorders · ZIA · FY2025 · DC
VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGED
$3,457,959Rafi Ahmed · Emory University · U19 · FY2006 · AI
NIDCD Core for Clinical Research and Care
$3,457,090Joshua Levy · National Institute On Deafness And Other Communication Disorders · ZID · FY2025 · DC
Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression
$3,455,370Justin Boike · Northwestern University At Chicago · U01 · FY2025 · AI
NEW METHODS FOR CANCER DETECTION
$3,453,975Weill Medical College Of Cornell Univ · P01 · FY2002 · CA
Research Initiatives on AIDS and HIV in the Division of Translational Toxicology
$3,453,000Janine Santos · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES